Stocks and Investing Stocks and Investing
Tue, March 9, 2021

Joseph Stringer Maintained (ACAD) at Strong Buy with Decreased Target to $44 on, Mar 9th, 2021


Published on 2024-10-27 15:53:19 - WOPRAI, Joseph Stringer
  Print publication without navigation


Joseph Stringer of Needham, Maintained "ACADIA Pharmaceuticals Inc." (ACAD) at Strong Buy with Decreased Target from $60 to $44 on, Mar 9th, 2021.

Joseph has made no other calls on ACAD in the last 4 months.



There is 1 other peer that has a rating on ACAD. Out of the 1 peers that are also analyzing ACAD, 0 agree with Joseph's Rating of Hold.



This is the rating of the analyst that currently disagrees with Joseph


  • Vamil Divan of "Mizuho" Initiated at Strong Buy and Held Target at $69 on, Wednesday, December 16th, 2020
Contributing Sources